T0	CompositeIntervention 25967 26096	caregiver education about the disease and instructions on coping, which were likely given at the beginning of and during the stud
T1	ExperimentalPhaseDuration 30667 30712	the short duration (12 week) of the RCT phase
T2	Blinding 30717 30761	the open-label design of the extension phase
T3	SampleSize 30773 30795	the small sample size.
T4	StudyDuration 30883 30972	it would be difficult to enroll patients with DLB in a long-term placebo-controlled trial
